PTO- 1957 |
Approved for use through 11/30/2023. OMB 0651-0050 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
---|---|
SERIAL NUMBER | 88846389 |
LAW OFFICE ASSIGNED | LAW OFFICE 118 |
MARK SECTION | |
MARK | mark |
LITERAL ELEMENT | COVIDTRAP |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size or color. |
GOODS AND/OR SERVICES SECTION (current) | |
INTERNATIONAL CLASS | 005 |
DESCRIPTION | |
Fusion protein pharmaceutical preparations for the treatment or prevention of infectious diseases; Pharmaceutical preparations for the treatment of COVID-19/Coronavirus | |
FILING BASIS | Section 1(b) |
GOODS AND/OR SERVICES SECTION (proposed) | |
INTERNATIONAL CLASS | 005 |
TRACKED TEXT DESCRIPTION | |
FINAL DESCRIPTION | |
Fusion protein pharmaceutical preparations for the treatment or prevention of infectious diseases, namely, COVID-19 and Coronavirus; Pharmaceutical preparations for the treatment of COVID-19/Coronavirus | |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
FILING BASIS | Section 1(b) |
ADDITIONAL STATEMENTS SECTION | |
MISCELLANEOUS STATEMENT | In response to the examiner's request for information, all of the goods will treat COVID 19. The goods are designed to treat SARS-COV-2 CORONAVIRUS DISEASE (COVID-19) by treating infected patients and acting as a potential prophylactic treatment to COVID-19. The goods will be distributed by medical professionals to the community at large. Attached are copies of webpages (and screenshots when the webpage printout omits information due to formatting issues), and news releases from website which provide additional information regarding the goods. |
MISCELLANEOUS FILE NAME(S) | |
JPG FILE(S) | \\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5 \ ROA0004.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0007.JPG | |
ORIGINAL PDF FILE | mis-389924698-20210302162 020887356_._COVIDTRAP_1.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0002.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0003.JPG | |
ORIGINAL PDF FILE | mis-389924698-20210302162 020887356_._COVIDTRAP_2.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0005.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0006.JPG | |
ORIGINAL PDF FILE | mis-389924698-20210302162 020887356_._COVIDTRAP_3.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0008.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0009.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0010.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0011.JPG | |
ORIGINAL PDF FILE | mis-389924698-20210302162 020887356_._COVIDTRAP_4.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0012.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0013.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0014.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\888\463\88846389\xml5\ ROA0015.JPG | |
CORRESPONDENCE INFORMATION (current) | |
NAME | LINDSAY J. HULLEY |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@rutan.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER | 035359.0013T |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Lindsay J. Hulley |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@rutan.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER | 035359.0013T |
SIGNATURE SECTION | |
RESPONSE SIGNATURE | /Lindsay J. Hulley/ |
SIGNATORY'S NAME | Lindsay J. Hulley |
SIGNATORY'S POSITION | Attorney of record |
SIGNATORY'S PHONE NUMBER | 714-641-5100 |
DATE SIGNED | 03/02/2021 |
ROLE OF AUTHORIZED SIGNATORY | Authorized U.S.-Licensed Attorney |
SIGNATURE METHOD | Signed directly within the form |
FILING INFORMATION SECTION | |
SUBMIT DATE | Tue Mar 02 19:18:05 ET 2021 |
TEAS STAMP | USPTO/ROA-XX.XX.XXX.XX-20 210302191805791120-888463 89-7704b831f6418e65f73076 fdc709bc9bd7a58f9ccca38ab ccc03b39fb6a0f175-N/A-N/A -20210302191643245693 |
PTO- 1957 |
Approved for use through 11/30/2023. OMB 0651-0050 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |